Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.

Abdel-Aziz A, Amin MM.

Diagn Pathol. 2012 Feb 2;7:14. doi: 10.1186/1746-1596-7-14.

2.

Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma.

Ahlem B, Wided A, Amani L, Nadia Z, Amira A, Faten F.

Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Nov;132(5):275-9. doi: 10.1016/j.anorl.2015.08.016. Epub 2015 Sep 16.

3.

The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy.

Yang Y, Xuan J, Yang Z, Han A, Xing L, Yue J, Hu M, Yu J.

Med Oncol. 2012 Sep;29(3):1448-55. doi: 10.1007/s12032-011-0028-4. Epub 2011 Jul 23.

PMID:
21786012
4.

Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.

Otero D, Lourenço SQ, Ruiz-Ávila I, Bravo M, Sousa T, de Faria PA, González-Moles MA.

Oral Dis. 2013 May;19(4):360-5. doi: 10.1111/odi.12010. Epub 2012 Sep 13.

PMID:
22970847
5.

Cystic ameloblastoma--behavior and treatment of 21 cases.

Rosenstein T, Pogrel MA, Smith RA, Regezi JA.

J Oral Maxillofac Surg. 2001 Nov;59(11):1311-6; discussion 1316-8.

PMID:
11688034
6.

Tumor cell proliferation and microsatellite alterations in human ameloblastoma.

Migaldi M, Sartori G, Rossi G, Cittadini A, Sgambato A.

Oral Oncol. 2008 Jan;44(1):50-60. Epub 2007 Feb 16.

PMID:
17307020
7.

CD10 expression in stromal cells of ameloblastoma variants.

Iezzi G, Piattelli A, Rubini C, Artese L, Goteri G, Fioroni M, Carinci F.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):206-9. Epub 2007 Oct 17.

PMID:
17942343
8.

CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.

Masloub SM, Abdel-Azim AM, Elhamid ES.

Diagn Pathol. 2011 May 24;6:44. doi: 10.1186/1746-1596-6-44.

9.

Epidermal growth factor receptor expression in ameloblastoma.

Vered M, Shohat I, Buchner A.

Oral Oncol. 2003 Feb;39(2):138-43. Review.

PMID:
12509966
10.
11.

P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas.

Florescu A, Simionescu C, Ciurea R, Pitru A.

Rom J Morphol Embryol. 2012;53(1):105-9.

12.

[Expression of Ki-67 antigen in ameloblastoma and its clinical significance].

Han B, Li L, Wang H.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2003 Apr 20;21(2):153-4. Chinese.

13.

Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma.

Janisson-Dargaud D, Durlach A, Lorenzato M, Grange F, Bernard P, Birembaut P.

J Cutan Pathol. 2008 Oct;35(10):916-21. doi: 10.1111/j.1600-0560.2007.00935.x. Epub 2008 Jun 5.

PMID:
18537864
14.

Histological pattern of mandibular invasion by oral squamous cell carcinoma.

Wong RJ, Keel SB, Glynn RJ, Varvares MA.

Laryngoscope. 2000 Jan;110(1):65-72.

PMID:
10646718
16.

Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.

Castellano I, Marchiò C, Tomatis M, Ponti A, Casella D, Bianchi S, Vezzosi V, Arisio R, Pietribiasi F, Frigerio A, Mano MP, Ricardi U, Allia E, Accortanzo V, Durando A, Bussolati G, Tot T, Sapino A.

Mod Pathol. 2010 Feb;23(2):260-9. doi: 10.1038/modpathol.2009.169. Epub 2009 Nov 13.

17.
19.

The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.

Roser F, Samii M, Ostertag H, Bellinzona M.

Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. Epub 2003 Dec 22.

PMID:
14740263
20.

Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.

Schindlbeck C, Hantschmann P, Zerzer M, Jahns B, Rjosk D, Janni W, Rack B, Sommer H, Friese K.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1047-55. Epub 2007 Apr 12.

PMID:
17433065

Supplemental Content

Support Center